ResearcherZhejiang Provincial People's HospitalActive in the last 2 years

郑晓春

ORCID-verified (high confidence)As of 15 November 2026

Matched on ORCID iD 0000-0002-6581-2427; OpenAlex author ID A5032330374.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2026: 1 paper

Papers 1

Economic evaluation of the second-line regimen of liposome irinotecan (II) combined with 5-FU/LV versus placebo combined with 5-FU/LV for locally advanced or m… Last author DOI 10.1371/journal.pone.0351853 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Jinlong Huang · 1 shared paper, 2026
- Paper Economic evaluation of the second-line regimen of liposome irinotecan (II) combined with 5-FU/LV versus placebo combine… DOI 10.1371/journal.pone.0351853 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.